课题基金 / 基金详情

项目摘要

项目成果

WILLIAM D ARNOLD的其他基金

相似基金

相关文献

中文摘要
翻译
我们提出了一个计算调查的相互作用的氨基糖苷类抗生素与30 S核糖体亚基。这些化合物是细菌翻译的抑制剂,是已知最古老的抗生素之一。由于它们的年龄和广泛使用,它们受到越来越多的细菌耐药性的影响。此外,尽管它们特异性靶向细菌核糖体,但它们也在较小程度上对真核核糖体起作用,导致人类毒性。最近解决的细菌30S核糖体的原子分辨率结构,无论是游离的还是与三种氨基糖苷类抗生素复合的,都为我们提供了一个前所未有的机会来设计新的药物,这些药物的细菌耐药因素尚未出现,并且对患者没有毒性。
英文摘要
We propose a computational investigation of the interaction of aminoglycoside antibiotics with the 30S ribosomal subunit. These compounds are inhibitors of bacterial translation, and are among the oldest known antibiotics. As a consequence of their age and wide use, they are subject to an increasing array of bacterial resistance. In addition, although they specifically target the bacterial ribosome, they also act to a lesser extent against the eukaryotic ribosome, resulting in human toxicity. The recently solved atomic resolution structure of the bacterial 30S ribosome, both free and complexed with three aminoglycoside antibiotics, provides us with an unprecedented opportunity to design new drugs for which bacterial resistance factors have not yet arisen, and which are not as toxic to patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Theoretical Studies of Bacterial Ribosome Antagonists
国内基金
海外基金
Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
  • 批准号:
    81971557
  • 项目类别:
    面上项目
  • 资助金额:
    65.0万元
  • 批准年份:
    2019
  • 负责人:
    毛开睿
  • 依托单位:
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制